SLC2A9 rs1126616: Understanding Your Genetic Urate Transporter
The rs1126616 variant is a specific genetic change located within the SLC2A9 gene. Research indicates this variant is associated with variations in serum uric acid levels and may influence an individual's susceptibility to gout.
What each genotype means
Typical uric acid profile
This genotype is associated with standard serum uric acid levels in many populations. Research indicates that individuals without the risk-associated allele generally maintain typical urate transport function via the SLC2A9 protein.
This is the most common genotype in many European populations, carried by approximately 60% of individuals.
Intermediate uric acid association
Carrying one copy of the variant may influence how your kidneys handle uric acid, potentially leading to slightly different serum levels compared to those without the variant. Statistical associations suggest this genotype contributes to the polygenic risk profile for hyperuricemia and gout.
This heterozygous genotype is found in roughly 30-35% of individuals in European populations.
Increased uric acid association
This genotype is statistically associated with higher serum uric acid levels and an increased susceptibility to gout in various studies. Because uric acid levels are influenced by many genetic and lifestyle factors, this result does not guarantee the development of gout; please discuss your overall metabolic health and any concerns with your clinician.
This genotype is less common, appearing in approximately 5-10% of individuals of European ancestry.
What is the rs1126616 Variant?
The rs1126616 variant is a single-nucleotide polymorphism (SNP) located within the SLC2A9 gene on chromosome 4. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is categorized as a functional exonic variant, meaning it occurs in a region of the gene that provides instructions for building proteins. Because it sits within the coding sequence, researchers have investigated whether it alters the structure or function of the resulting protein. Geneticists track these markers to understand how small differences in our DNA code can lead to measurable differences in biological traits, such as how the body processes metabolic waste products like uric acid.
The Role of the SLC2A9 Gene
The SLC2A9 gene provides the instructions for creating a protein known as glucose transporter 9 (GLUT9). While its name suggests a role in sugar transport, GLUT9 is primarily recognized for its high-capacity ability to transport urate, a byproduct of purine metabolism. This protein is highly expressed in the proximal tubules of the kidneys, which are the structures responsible for filtering blood and reabsorbing essential nutrients while excreting waste. By regulating the movement of urate, the GLUT9 protein plays a critical role in maintaining the balance of uric acid in the bloodstream. When this transport process is altered, it can lead to hyperuricemia, a condition characterized by elevated levels of uric acid in the blood, which is a primary risk factor for developing gout.
Research and Evidence Strength
The association between SLC2A9 variants and uric acid levels is well-documented in genome-wide association studies (GWAS). Research has consistently shown that variations in this gene can explain a small but significant percentage of the variance in serum uric acid concentrations across different populations. Specifically, the rs1126616 variant has been linked to susceptibility to gout, an inflammatory arthritis caused by the buildup of monosodium urate crystals in the joints. However, the evidence strength for this specific variant is currently considered limited. While the biological link between SLC2A9 and urate transport is strong, gout is a complex, multifactorial condition. It is rarely caused by a single genetic variant alone; rather, it results from a combination of genetic predisposition, dietary habits, and other environmental factors. Therefore, having a specific genotype at this location does not guarantee the development of gout.
Understanding Your Results
If you have information about your genotype for rs1126616, it is important to view it as one piece of a much larger puzzle. Genetic associations are statistical observations made across large groups of people, not diagnostic tools for individuals. Because gout is influenced by many factors—including diet, lifestyle, kidney function, and other genetic markers—your genotype at this single location cannot predict your personal health outcomes. You cannot use this information to diagnose yourself or to make medical decisions. If you are concerned about your uric acid levels, joint health, or gout risk, the most effective step is to consult with a healthcare professional. They can evaluate your clinical history, perform necessary blood tests, and provide guidance tailored to your specific health needs.
How common is this variant?
The minor allele frequency for rs1126616 is approximately 0.20 to 0.25 in European populations, meaning the variant is relatively common in these groups.
Frequently asked questions
Does having the rs1126616 variant mean I will get gout?
No. Genetic variants like rs1126616 are associated with a statistical increase in risk, but they do not cause gout on their own. Gout is a complex condition influenced by diet, lifestyle, and many other genetic and environmental factors.
Can I change my SLC2A9 gene expression?
You cannot change your DNA sequence. However, managing uric acid levels through diet, hydration, and medical supervision as advised by your doctor can help manage the physiological effects associated with urate transport.
Is SLC2A9 the only gene linked to gout?
No, gout is polygenic, meaning it is influenced by many different genes. Other genes, such as ABCG2, are also well-known for their roles in urate transport and gout susceptibility.
Should I get tested for this variant?
Genetic testing for common variants like rs1126616 is generally not used for clinical diagnosis of gout. If you have symptoms of gout, a doctor will typically rely on physical exams and blood tests for uric acid rather than genetic screening.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1126616?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in SLC2A9
Common missense-associated variant in GLUT9 modulating serum urate homeostasis and risk of gout.
This SNP is linked to variations in serum uric acid levels and the risk of developing gout.
Increases the risk of high uric acid levels and gout.